Chemomab Therapeutics LTD. (CMMB) SEC Filings — 2025

Filings

• Chemomab Therapeutics LTD. 6-K Filing — 6-K · Nov 21, 2025
• Chemomab Therapeutics Announces ADS Ratio Adjustment — 6-K · Aug 22, 2025
• Chemomab Therapeutics Ltd. Files Form 6-K — 6-K · Aug 14, 2025
• Chemomab Therapeutics Ltd. Enters Sales Agreement — 6-K · Jul 25, 2025
• Chemomab Therapeutics Ltd. Holds Annual Shareholder Meeting — 6-K · Jul 1, 2025
• Chemomab Therapeutics Files 6-K for Shareholder Meeting — 6-K · May 27, 2025
• Chemomab Therapeutics Reports Q1 2025 Results — 6-K · May 15, 2025
• Chemomab Therapeutics Announces CMO Departure, Appoints Interim — 6-K · Apr 15, 2025
• Chemomab Therapeutics Files 20-F, Reports Capital Losses — 20-F · Apr 4, 2025
• Chemomab Therapeutics Reports Positive Phase 2 Nebokitug PSC Trial Results — 6-K · Mar 27, 2025
• Chemomab Therapeutics Files 6-K with Prospectus Supplement Details — 6-K · Mar 20, 2025
• Chemomab Therapeutics Reports 2024 Financials & Update — 6-K · Mar 3, 2025
• Chemomab Therapeutics Clears FDA Path for Nebokitug — 6-K · Feb 19, 2025